U.S. Approves Lung Cancer Drug Priced at $780,000
The U.S. has recently approved the drug tarlatamab-dlle for the treatment of metastatic small cell lung cancer, priced at $780,000 for one year of treatment.The decision was made by the ...
Tag: tarlatamab-dll drug
